Blocking effects of siRNA on VEGF expression in human colorectal cancer cells

doi:10.3748/wjg.v16.i9.1086

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3453)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

367

HTML

2764

Figures (1-4)

157

Tables (1-2)

165

Sum=3453

Mar 7, 2010 (publication date) through May 17, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 7, 2010; 16(9): 1086-1092
Published online Mar 7, 2010. doi: 10.3748/wjg.v16.i9.1086

Table 1 Expression of VEGF and its receptors FLT-1 and FLK-1 in CRC and normal mucosa n (%)

	n	VEGF		FLT-1		FLK-1
	n	Negative	Positive	Negative	Positive	Negative	Positive
Normal mucosa	14	10	4 (28.6)	9	5 (35.7)	10	4 (28.6)
CRC	82	25	57 (69.5)^b	14	68 (82.9)^b	15	67 (81.7)^b

^bP < 0.01 vs normal mucosa. VEGF: Vascular endothelial cell growth factor; FLT-1: Fms-like tyrosine kinase 1; FLK-1: Fetal liver kinase 1; CRC: Colorectal carcinoma.

Citation: Yin Y, Cao LY, Wu WQ, Li H, Jiang Y, Zhang HF. Blocking effects of siRNA on VEGF expression in human colorectal cancer cells. World J Gastroenterol 2010; 16(9): 1086-1092
URL: https://www.wjgnet.com/1007-9327/full/v16/i9/1086.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i9.1086